• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; INTRA- AORTIC BALLOON FIBER OPTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; INTRA- AORTIC BALLOON FIBER OPTIC Back to Search Results
Catalog Number IAB-05840-LWS
Device Problem Gas/Air Leak (2946)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/12/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the event occurred while in the cardiac theatre.The intra-aortic balloon (iab) was prepared and zeroed as per information for use (ifu) and proceeded with insertion of the iab.The iab was inserted via the patient's left femoral artery during cardiac surgery.Some difficulty was noted during insertion but was attributed to patient related issues.Iabp therapy was commenced and after several minutes there was a helium loss alarm.The perfusionist checked all connections and looked for presence of blood.Having ruled that out, he recommenced iabp therapy.A repeat helium loss alarm occurred, and after several attempts to restart, the perfusionist called clinical support.After some discussion, it was decided that there was presence of a catheter abrasion the surgeon decided to replace the iab.The second iab was inserted without any issue and iabp therapy commenced with no further issues.The second iab was inserted via the same insertion site.There was approximately a 10 minute delay/interruption in iabp therapy.There was reported medical / surgical intervention required and described as removal of and replacement of iab into the same insertion site.There was no reported patient death, injury or complications.The patient received iabp therapy successfully.
 
Manufacturer Narrative
Qn#(b)(4).A small amount of dried blood was noted within the intra- aortic balloon (iab) bladder membrane at the tip of the catheter.The bladder membrane was fully unwrapped.The fiber was found puncturing the bladder membrane approximately 1.5cm from the distal tip of the catheter.No kinks or bends were noted to the device.The fiber-optix sensor (fos) and cal key were examined.The gray fos connecter was properly seated in the housing and both retaining tabs were intact.The center post of the fos was centered.The blue clamshell housing was examined and no abnormalities were noted.The cal key was intact.The bladder thickness was measured at six points with measurements within specification.The one-way valve was tested and passed.A vacuum was pulled on the one-way valve and it held for at least 1 minute and then 30 seconds five separate times.The fos and cal key were connected to the iabp.The pump displayed a "ll pl" status indicating a potential broken fiber.The fiber was found broken approximately 1.2cm from the distal tip.The iab was submerged in water and leak tested.A leak was found approximately 1.5cm from the distal tip.Under microscopic inspection, a puncture consistent with contact from the broken fiber was found.See other remarks section.Other remarks: a device history record (dhr) review was conducted for the lot number/serial number with no relevant findings.The device passed all manufacturing specifications prior to release.Conclusion: the reported complaint of helium loss alarms is confirmed.A puncture consistent with contact from the broken fiber was found near the distal tip of the catheter which likely caused the pump to alarm for helium loss.The root cause of the broken fiber is undetermined.Teleflex will continue to monitor for similar reported complaints.
 
Event Description
It was reported that the event occurred while in the cardiac theatre.The intra-aortic balloon (iab) was prepared and zeroed as per information for use (ifu) and proceeded with insertion of the iab.The iab was inserted via the patient's left femoral artery during cardiac surgery.Some difficulty was noted during insertion but was attributed to patient related issues.Iabp therapy was commenced and after several minutes there was a helium loss alarm.The perfusionist checked all connections and looked for presence of blood.Having ruled that out, he recommenced iabp therapy.A repeat helium loss alarm occurred, and after several attempts to restart, the perfusionist called clinical support.After some discussion, it was decided that there was presence of a catheter abrasion the surgeon decided to replace the iab.The second iab was inserted without any issue and iabp therapy commenced with no further issues.The second iab was inserted via the same insertion site.There was approximately a 10 minute delay/interruption in iabp therapy.There was reported medical / surgical intervention required and described as removal of and replacement of iab into the same insertion site.There was no reported patient death, injury or complications.The patient received iabp therapy successfully.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 40CC
Type of Device
INTRA- AORTIC BALLOON FIBER OPTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
9 plymouth street
everett MA 02149
Manufacturer Contact
anne rosenberger
2400 bernville road
reading, PA 19605
6104783117
MDR Report Key6106081
MDR Text Key60028789
Report Number1219856-2016-00253
Device Sequence Number1
Product Code DSP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/21/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2018
Device Catalogue NumberIAB-05840-LWS
Device Lot Number18F16G0052
Other Device ID Number00801902007247
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/31/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/15/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/30/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-